RenovoRx Stock (NASDAQ: RNXT) stock price, news, charts, stock research, profile.
Open | $1.16 |
Close | $1.03 |
Volume / Avg. | 143.54K / 34.08K |
Day Range | $0.98 - $1.19 |
52 Wk Range | 0.53 - 2.35 |
Market Cap | $28.30M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 0.23% |
Days to Cover | 1.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.
Other companies in RenovoRx’s space includes: Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Burning Rock Biotech (NASDAQ:BNR), Lumos Pharma (NASDAQ:LUMO) and Aligos Therapeutics (NASDAQ:ALGS).
RenovoRx has a consensus price target of $10.31.
The stock price for RenovoRx (NASDAQ: RNXT) is $1.18 last updated September 23, 2024 at 9:24 AM EDT.
There are no upcoming dividends for RenovoRx.
RenovoRx’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for RenovoRx.
RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.